Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study

Regina I. Jakacki, Margaret A. Foley, Julie Horan, Jiuzhou Wang, Mark W. Kieran, Daniel C. Bowers, Eric Bouffet, Stergios Zacharoulis, Stan C. Gill

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint Dive into the research topics of 'Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study'. Together they form a unique fingerprint.

Medicine & Life Sciences